Skip Navigation



Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Neurologic Disorders
Location: United States, NY

Clinical Trial Details


Research Study Summary

Clinical Studies of Patients with Paraneoplastic Neurologic Disorders


We are studying patients with paraneoplastic neurologic disorders (The Hu syndrome, a.k.a. Paraneoplastic Subacute Sensory Neuropathy/Encephalomyelitis or Limbic Encephalopathy, and The Ri Syndrome, a.k.a. Paraneoplastic Opsoclonus-Myoclonus Ataxia) in two IRB-approved protocols at the Rockefeller University Clinical Research Center. One study is aimed at furthering our understanding of the cause of these disorders, and a second is a treatment protocol based on our laboratory studies.

All patients with paraneoplastic neurologic disorders are eligible, including patients with:

  • Paraneoplastic Cerebellar Degeneration
  • The Hu Syndrome
    • Paraneoplastic Subacute Sensory Neuropathy/Encephalomyelitis
    • Limbic Encephalopathy
  • Paraneoplastic Opsoclonus-Myoclonus Ataxia (The Ri Syndrome)
To Learn more

Both Male and Female



Overall Status


Facility Type



Mayu Frank
The Rockefeller University Hospital
1230 York Avenue
New York, NY 10021-6399
Phone: 212-327-7443

View Map

Research Center Information: The Rockefeller University Hospital

CW ID: 23171

Date Last Changed: July 25, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.